<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Elevations in blood pressure and visit-to-visit variability have been found to significantly increase the risk of <z:e sem="disease" ids="C1301700" disease_type="Disease or Syndrome" abbrv="">cardiovascular morbidity</z:e> and mortality in nondiabetic individuals </plain></SENT>
<SENT sid="1" pm="."><plain>This study has assessed the association between <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality and blood pressure parameters [systolic blood pressure (SBP), diastolic blood pressure (<z:chebi fb="4" ids="35861">DBP</z:chebi>), pulse pressure (PP), mean arterial pressure (MAP) and visit-to-visit variability] in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: A longitudinal cohort study of 2161 patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and a mean follow-up period of 66·7 ± 7·5 months </plain></SENT>
<SENT sid="3" pm="."><plain>Using Cox regression models, blood pressure parameters were related to the risk of <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Visit-to-visit variability in SBP [HR: 1·048 (95% CI: 1·005-1·092; P = 0·03)], <z:chebi fb="4" ids="35861">DBP</z:chebi> [HR: 1·090 (95% CI: 1·021-1·163; P = 0·01)] and MAP [HR: 1·099 (95% CI: 1·033-1·170; P = 0·003)] significantly predicted <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> after adjusting for baseline data, mean follow-up blood pressure profiles and HbA1c </plain></SENT>
<SENT sid="5" pm="."><plain>Visit-to-visit variability in PP [HR: 1·139 (95% CI: 1·030-1·258; P = 0·01)] significantly predicted cardiovascular mortality </plain></SENT>
<SENT sid="6" pm="."><plain>Neither baseline nor follow-up SBP, <z:chebi fb="4" ids="35861">DBP</z:chebi>, PP nor MAP was significantly associated with <z:hpo ids='HP_0000001'>all</z:hpo>-cause and cardiovascular mortality after adjusting for blood pressure variability </plain></SENT>
<SENT sid="7" pm="."><plain>The risk of <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality with a mean follow-up SBP has a U-shaped distribution </plain></SENT>
<SENT sid="8" pm="."><plain>Patients with a mean follow-up <z:chebi fb="4" ids="35861">DBP</z:chebi> &gt; 90 mmHg were at higher risk of mortality than those with <z:chebi fb="4" ids="35861">DBP</z:chebi> &lt; 90 mmHg </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS: Visit-to-visit variability in blood pressure was significantly associated with <z:hpo ids='HP_0000001'>all</z:hpo>-cause mortality independent of mean BP in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>The data for blood pressure variability might be regarded as a potentially important therapeutic target in the management of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
</text></document>